Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7
Primary Industries
- Medical
- Device
- Delivery
- Ambulatory
- Disposable
- Infusion
- Pump
- Catheter
- Diagnostic
- Wound Care
- Therapeutic
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 7756
License Grant
The agreement included a patent License Agreement which grants the worldwide rights to the disposable ambulatory infusion pump, or DAI Pump.
License Property
The DAI Pump, a medical device which pumps a continuous flow of therapeutic drugs into the blood stream at an adjustable flow rate.
IPSCIO Record ID: 180208
License Grant
The company entered into an agreement providing the company with exclusive rights in the United States and certain other countries to develop Licensors proprietary intravascular infusion catheter to be used with its SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of pulmonary arterial hypertension (PAH).
License Property
The proprietary intravascular infusion catheter is to be used with its SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of PAH. The Implantable System for Remodulin will be exclusive to Remodulin so long as we purchase a minimum percentage of our annual requirement for implantable pump systems from Licensor.
Field of Use
This agreement pertains to the medical industry.
IPSCIO Record ID: 27452
License Grant
The Licensor hereby grants to the Company the perpetual, fully paid and irrevocable right and license (hereinafter referred to as the 'License') to (I) exclusively (1) manufacture, assemble, produce, sell and distribute to Customers in the Territory, and (2) cause to be manufactured, assembled, produced, sold and distributed to Customers in the Territory by one or more Affiliates or sublicensees of the Company as it may from time to time select, the Pump Components excluding, however, the manufacture, production, or assembly of the Spring Assemblies.
The Company has the exclusive U.S. marketing rights and license for an ambulatory infusion–a round, spring-driven infusion pump with dedicated administration sets and related accessories which also includes an electronic alarm to denote the completion of an infusion.
License Property
SideKick Infusion System — a round, spring-driven infusion pump with dedicated administration sets and related accessories; (ii) the Paragon Infusion System — a round, spring-driven infusion pump with dedicated administration sets and related accessories; and (iii) the Paragon elite Infusion System –a round, spring-driven infusion pump with dedicated administration sets and related accessories which also includes an electronic alarm to denote the completion of an infusion.
Field of Use
The companion product SIDEKICK utilizes a patented spring technology to deliver IV antibiotics over a shorter time period.
IPSCIO Record ID: 7800
License Grant
The Israel Licensor hereby irrevocably assigns and transfers to the Israel Licensee in Formation all rights in the Application for Patent Registration and the Disposal Equipment.
License Property
The Licensor is the owner of rights in the application for a patent registration number US 60/917,075 or any other right in connection with disposable equipment for insulin pumps.
Field of Use
The Licensee wishes to form a company that will receive the rights in the Application for Patent Registration and which shall act in developing, marketing, selling and/or any other act in connection with the Disposal Equipment.
IPSCIO Record ID: 26013
License Grant
The Licensor hereby grants to Licensee, the right and worldwide exclusive License, and the worldwide nonexclusive subLicense the technology.
License Property
The rights Licensed to Licensee hereunder shall extend to its affiliates designated in writing by Licensee.
Licensee shall have the exclusive right under patent rights and the nonexclusive right under License rights to grant subLicenses to third parties other than affiliates in its discretion.
The technology is entitled Speed Control System for Implanted Blood Pumps, US. Patent No. 5,888,242 (filed November 1, 1996), and US. Patent No. 6,066,086 Speed control system for implanted blood pumps (filed March 4, 1998), including the right to subLicense such technology.
Field of Use
Speed control system for implanted blood pumps
IPSCIO Record ID: 1804
License Grant
The Company hereby grants the worldwide right to manufacture, cause to be manufactured, promote, sell, market, distribute and use the Pump Technology; programmable implantable insulin pump system.
License Property
Implantable microinfusion pump systems intended for in vivo use; utilizes Pump Technology for diabetes or non-diabetes applications. Glucose Controllers, Glucose Monitors, Long-Term Glucose Sensors and the abdominal lead that connects the implantable pump to a Long-Term Glucose Sensor are not Licensed Products. An apparatus or system which utilizes Glucose Sensing Technology to control an insulin infusion device in a human or in an animal. Any monitor product utilizing Glucose Sensing Technology to provide indications of glucose concentration or changes in glucose concentration in a human or in an animal.
IPSCIO Record ID: 7545
License Grant
The Licensor grants the Licensee, in the United States, during the term of this Agreement, a non-exclusive right and license to use the Know-How for the manufacture and/or Support of the Licensed Product for negative pressure wound treatment applications. An exclusive right and license to market, sell lease and/or distribute, whether directly or via dealers, distributors and sales agents, the Licensed Product in and to the Market for negative pressure wound treatment applications.
An exclusive right and license to sell and/or provide in the Market Support for any Licensed Product sold by Licensor or its dealers to customers and a non-exclusive right and license, with the right to sub-license, to design, develop, and implement modifications, improvements, and derivate works of the Licensed Product for negative pressure wound treatment applications.
A non-exclusive right and license to integrate and/or incorporate the Licensed Product with Licensor products to create Integrated Products, and to market, sell, lease, and/or distribute such Integrated Products in the Market, in the United States.
An exclusive right and license to sell and/or provide in the Market Support for any Licensed Product sold by Licensor or its dealers to customers and a non-exclusive right and license, with the right to sub-license, to design, develop, and implement modifications, improvements, and derivate works of the Licensed Product for negative pressure wound treatment applications.
A non-exclusive right and license to integrate and/or incorporate the Licensed Product with Licensor products to create Integrated Products, and to market, sell, lease, and/or distribute such Integrated Products in the Market, in the United States.
License Property
Licensor has designed, developed, and obtained licensing rights to a wound treatment ultrasound system, a wound instillation system, and wound oxygenation technology, which can be used together with the Licensee negative pressure wound treatment or separately.
United States Patent
7,284,965
Compact vacuum pump
United States Patent
7,918,654
Compact vacuum pump
United States Patent
7,503,910
Suctioning system, method and kit
United States Patent
7,758,539
Compact vacuum pump
Field of Use
The NPWT (negative wound pressure therapy) is an established technology – a small, lightweight pump with features that allow contamination-free handling of infected wound exudate (fluid) and enhanced patient mobility.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
